GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » FCF Margin %

Mainz Biomed NV (Mainz Biomed NV) FCF Margin % : -2,286.98% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mainz Biomed NV's Free Cash Flow for the three months ended in Dec. 2023 was $-4.92 Mil. Mainz Biomed NV's Revenue for the three months ended in Dec. 2023 was $0.22 Mil. Therefore, Mainz Biomed NV's FCF Margin % for the quarter that ended in Dec. 2023 was -2,286.98%.

As of today, Mainz Biomed NV's current FCF Yield % is -190.51%.

The historical rank and industry rank for Mainz Biomed NV's FCF Margin % or its related term are showing as below:

MYNZ' s FCF Margin % Range Over the Past 10 Years
Min: -2910.94   Med: -561.01   Max: -96.96
Current: -2660.49


During the past 5 years, the highest FCF Margin % of Mainz Biomed NV was -96.96%. The lowest was -2910.94%. And the median was -561.01%.

MYNZ's FCF Margin % is ranked worse than
96.4% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs MYNZ: -2660.49


Mainz Biomed NV FCF Margin % Historical Data

The historical data trend for Mainz Biomed NV's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV FCF Margin % Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
-148.04 -96.96 -561.01 -2,910.94 -2,663.46

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,449.22 -2,824.00 -2,105.62 -3,636.26 -2,286.98

Competitive Comparison of Mainz Biomed NV's FCF Margin %

For the Diagnostics & Research subindustry, Mainz Biomed NV's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mainz Biomed NV's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's FCF Margin % falls into.



Mainz Biomed NV FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mainz Biomed NV's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-23.838/0.895
=-2,663.46 %

Mainz Biomed NV's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-4.917/0.215
=-2,286.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mainz Biomed NV FCF Margin % Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mainz Biomed NV (Mainz Biomed NV) Business Description

Traded in Other Exchanges
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.